Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in Antiphospholipid Syndrome Pilot Study
NCT02116036Phase 4Completed
- Sponsor
- St. Joseph's Healthcare Hamilton
- Start
- Sep 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in antiphospholipid syndrome (APS), sponsored by St. Joseph's Healthcare Hamilton. Started Sep 2014; status: completed.
02
Drugs
rivaroxaban
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT02116036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02116036.